Nipro PharmaPackaging Expands Global Leadership in Pharmaceutical Glass Packaging in France and USA
Nipro PharmaPackaging is intensifying its global presence as a premier supplier of glass primary packaging for pharmaceuticals with a substantial $60 million investment in France and the USA. This initiative focuses on expanding capacity at its facilities in Aumale, France, and Millville, New Jersey, USA, to meet rising global demand. Scheduled to begin production in 2021 and reach full capacity by 2024, the investment will create approximately 70 new jobs, primarily in Aumale.
The expansion aims to enhance production capabilities for high-quality glass tubing, critical for injectable medicines. Nipro's commitment to maintaining stringent quality standards and sustainability is underscored by advancements in technology, which aim to reduce CO² emissions and energy consumption. This strategic move reinforces Nipro's position as a leader in pharmaceutical packaging, ensuring consistent supply amid growing regulatory scrutiny in the healthcare industry.